Richard M. Kimes

Richard M. Kimes discloses dealings in REVA Medical, Inc. to SEC (Form 4). We count 5 filings; the first trade dates from 29 March 2016 and the latest from 29 June 2018.

The open-market record is one-sided, with 3 purchases worth €12k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants. In 2018 alone, the filings show 1 purchase and no sales.

A typical purchase (the median) is worth €4,214. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 2 July 2018 with an open-market purchase (€4,329) in REVA Medical, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.